Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
Leidos Stock Up 0.4 %
Shares of Leidos stock traded up $0.44 on Thursday, reaching $101.59. The company's stock had a trading volume of 318,761 shares, compared to its average volume of 915,028. The company has a market capitalization of $13.87 billion, a price-to-earnings ratio of 19.73, a P/E/G ratio of 2.30 and a beta of 0.71. The firm's fifty day simple moving average is $100.17 and its two-hundred day simple moving average is $101.37. Leidos has a 52 week low of $81.07 and a 52 week high of $111.12. The company has a quick ratio of 0.83, a current ratio of 0.90 and a debt-to-equity ratio of 0.99.
Leidos (NYSE:LDOS - Get Rating) last posted its earnings results on Tuesday, August 2nd. The aerospace company reported $1.59 EPS for the quarter, topping analysts' consensus estimates of $1.55 by $0.04. The business had revenue of $3.60 billion during the quarter, compared to analyst estimates of $3.52 billion. Leidos had a return on equity of 22.18% and a net margin of 5.15%. The company's quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.52 EPS. Equities analysts anticipate that Leidos will post 6.35 earnings per share for the current year.
Leidos Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Thursday, September 15th will be paid a $0.36 dividend. The ex-dividend date is Wednesday, September 14th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.42%. Leidos's dividend payout ratio (DPR) is currently 27.96%.
Analyst Ratings Changes
A number of research analysts have recently commented on the company. Morgan Stanley raised their target price on Leidos from $107.00 to $110.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 3rd. Wells Fargo & Company lowered their target price on Leidos from $109.00 to $105.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 3rd. Truist Financial raised their price objective on Leidos from $108.00 to $120.00 in a research report on Wednesday, May 4th. Finally, Barclays lowered Leidos from an "overweight" rating to an "equal weight" rating and set a $105.00 price objective for the company. in a research report on Tuesday, June 7th. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Leidos has a consensus rating of "Moderate Buy" and a consensus target price of $113.00.
Insider Transactions at Leidos
In other news, insider James Robert Moos sold 516 shares of the firm's stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $98.56, for a total value of $50,856.96. Following the transaction, the insider now directly owns 21,391 shares in the company, valued at approximately $2,108,296.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Director Harry M. Jansen Kraemer, Jr. sold 7,274 shares of Leidos stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $103.18, for a total transaction of $750,531.32. Following the transaction, the director now directly owns 84,277 shares in the company, valued at $8,695,700.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider James Robert Moos sold 516 shares of Leidos stock in a transaction on Wednesday, June 15th. The shares were sold at an average price of $98.56, for a total value of $50,856.96. Following the transaction, the insider now owns 21,391 shares in the company, valued at $2,108,296.96. The disclosure for this sale can be found here. Company insiders own 1.67% of the company's stock.
